Efficacy of iron and nutrition supplementations in improving the growth parameters of underweight children, A open labeled multiarm randomised control study

Role of Iron supplements, Nutritional supplements and Nutrition education in management of underweight children; An open labeled multiarm randomised control trial. - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057709

Enrollment

150

Registered

2023-09-15

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E441- Mild protein-calorie malnutrition

Interventions

Intervention1: Iron and multivitamin supplement: Iron supplement Preparations containing ferrous polymaltose with elemental Iron at concentrations of 5ml/ 50 mg Dose 3mg /kg/day for 3 months Multivi

Eligibility

Inclusion criteria

Inclusion criteria: apparently healthy children between ages 2-5 years weight for age falling between 2SD and 3SD as per WHO growth standard willing to participate in the study

Exclusion criteria

Exclusion criteria: Children with pre-exsisting renal/hepatic/ heart disease lactose intolerance malabsorption recent PICU admissions severe anemia

Design outcomes

Primary

Measure	Time frame
to evaluate the effect of iron & multivitamin supplementation nutritional supplementation & nutritional education in improving the growth parameters (weight, height, weight for height, mid arm circumference) among underweight childrenTimepoint: every month over a period of 3months	—

Secondary

Measure	Time frame
to compare the compliance & acceptability profile by children for the 3 interventionTimepoint: 3months	—

Countries

India

Contacts

Public Contactkarunya r

SRM Medical College Hospital and Research Center

balajic1@srmist.edu.in09940324828

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026